pembrolizumab
merck
['pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'renal,(-adrenal)', 'key,note,564', ' uc,(-ucsd),(-ucsf),']
#ascogu23 adjuvant pembrolizumab (pembro) for renal cell carcinoma (rcc) across ucla integrated staging system (uiss) risk groups and disease stage: subgroup analyses from the keynote-564 study. 
Medicina Interna - Oncología Clínica - Clínica Astorga. Profesor titular @upbcolombia #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis